The Postprandial-to-Fasting Serum C-Peptide Ratio is a Predictor of Response to Basal Insulin-Supported Oral Antidiabetic Drug(s) Therapy: A Retrospective Analysis

INTRODUCTION: Basal insulin is widely recommended for the treatment of type 2 diabetes mellitus (T2DM) patients who are unable to achieve glycemic control with oral antidiabetic drug(s) (OADs). However, some patients are still unable to control their blood glucose levels even when on basal insulin-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Pan-wei, Liu, De-zhao, Lin, Ying, Liu, Dong, Zhang, Fan, Zhang, Yong-jun, Lin, Shuo, Wang, Lin-qin, Wang, Man-man, Shu, Jiong, Zeng, Long-yi, Chen, Yan-ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984910/
https://www.ncbi.nlm.nih.gov/pubmed/29564716
http://dx.doi.org/10.1007/s13300-018-0404-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984910/
https://www.ncbi.nlm.nih.gov/pubmed/29564716
http://dx.doi.org/10.1007/s13300-018-0404-6

Ejemplares similares